Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isotretinoin for Recurrent Dermatophytosis (ISORD)
NCT03471455Phase 2Unknown
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Apr 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of isotretinoin in dermatophytosis, sponsored by Post Graduate Institute of Medical Education and Research. Status: unknown.
02
Drugs
isotretinoin
03
Conditions
dermatophytosis
Beyond the preview
Go deeper on NCT03471455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03471455.